Charu Mehta - Publications

Affiliations: 
2014-2020 CELL AND REGENERATIVE BIOLOGY University of Wisconsin School of Medicine and Public Health, Madison, WI, United States 

18 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Katsumura KR, Liu P, Kim JA, Mehta C, Bresnick EH. Pathogenic GATA2 genetic variants utilize an obligate enhancer mechanism to distort a multilineage differentiation program. Proceedings of the National Academy of Sciences of the United States of America. 121: e2317147121. PMID 38422019 DOI: 10.1073/pnas.2317147121  0.617
2022 Fraga de Andrade I, Johnson KD, Mehta C, Dewey C, Basu U, Bresnick EH. RNA-Regulatory Exosome Complex Suppresses an Apoptotic Program to Confer Erythroid Progenitor Cell Survival In Vivo. Blood Advances. PMID 36161469 DOI: 10.1182/bloodadvances.2022008481  0.582
2021 Mehta C, Fraga de Andrade I, Matson DR, Dewey CN, Bresnick EH. RNA-regulatory exosome complex confers cellular survival to promote erythropoiesis. Nucleic Acids Research. PMID 34059908 DOI: 10.1093/nar/gkab367  0.623
2020 Zwifelhofer NM, Cai X, Liao R, Mao B, Conn DJ, Mehta C, Keles S, Xia Y, Bresnick EH. GATA factor-regulated solute carrier ensemble reveals a nucleoside transporter-dependent differentiation mechanism. Plos Genetics. 16: e1009286. PMID 33370779 DOI: 10.1371/journal.pgen.1009286  0.542
2020 Fraga de Andrade I, Mehta C, Bresnick EH. Post-transcriptional control of cellular differentiation by the RNA exosome complex. Nucleic Acids Research. PMID 33119769 DOI: 10.1093/nar/gkaa883  0.523
2020 You X, Chang YI, Kong G, Ranheim EA, Zhou Y, Johnson KD, Mehta C, Bresnick EH, Zhang J. Gata2 -77 enhancer regulates adult hematopoietic stem cell survival. Leukemia. PMID 32594099 DOI: 10.1038/S41375-020-0942-6  0.575
2020 Cavalcante de Andrade Silva M, Katsumura KR, Mehta C, Velloso EDRP, Bresnick EH, Godley LA. Breaking the spatial constraint between neighboring zinc fingers: a new germline mutation in GATA2 deficiency syndrome. Leukemia. PMID 32286542 DOI: 10.1038/S41375-020-0820-2  0.526
2019 Soukup AA, Zheng Y, Mehta C, Wu J, Liu P, Cao M, Hofmann I, Zhou Y, Zhang J, Johnson KD, Choi K, Keles S, Bresnick EH. Single-nucleotide human disease mutation inactivates a blood-regenerative GATA2 enhancer. The Journal of Clinical Investigation. PMID 30620726 DOI: 10.1172/Jci122694  0.64
2019 Katsumura KR, Liu P, Mehta C, Hewitt KJ, Soukup A, Fraga de Andrade IJ, Ranheim EA, Johnson KD, Bresnick EH. Loss-of-Function and Gain-of-Function Consequences of GATA2 Disease Mutations Blood. 134: 2519-2519. DOI: 10.1182/Blood-2019-129447  0.63
2019 Mehta C, Fraga de Andrade IJ, Tanimura N, Wilson GM, Ranheim EA, Coon JJ, Bresnick EH. Elucidating an Erythroblast Survival Mechanism: Differential Contributions of Exosome Complex Catalytic Subunits Blood. 134: 155-155. DOI: 10.1182/Blood-2019-126917  0.608
2018 Katsumura KR, Mehta C, Hewitt KJ, Soukup AA, Fraga de Andrade I, Ranheim EA, Johnson KD, Bresnick EH. Human leukemia mutations corrupt but do not abrogate GATA-2 function. Proceedings of the National Academy of Sciences of the United States of America. PMID 30301799 DOI: 10.1073/Pnas.1813015115  0.645
2018 Bresnick EH, Hewitt KJ, Mehta C, Keles S, Paulson RF, Johnson KD. Mechanisms of erythrocyte development and regeneration: implications for regenerative medicine and beyond. Development (Cambridge, England). 145. PMID 29321181 DOI: 10.1242/Dev.151423  0.582
2018 McIver SC, Hewitt KJ, Gao X, Mehta C, Zhang J, Bresnick EH. Dissecting Regulatory Mechanisms Using Mouse Fetal Liver-Derived Erythroid Cells. Methods in Molecular Biology (Clifton, N.J.). 1698: 67-89. PMID 29076084 DOI: 10.1007/978-1-4939-7428-3_4  0.611
2018 Soukup A, Mehta C, Liu P, Cao M, Hofmann I, Zhou Y, Zhang J, Choi K, Johnson KD, Bresnick EH. Single-Nucleotide Human Disease Mutation Inactivates a Blood-Regenerative Enhancer Blood. 132: 2564-2564. DOI: 10.1182/Blood-2018-99-113008  0.565
2018 Soukup A, Johnson K, Mehta C, Zhou Y, Zhang J, Bresnick E. GATA-2 Dependent Hematologic Disease Mechanism Experimental Hematology. 64: S45. DOI: 10.1016/J.Exphem.2018.06.054  0.521
2017 Mehta C, Johnson KD, Gao X, Ong I, Katsumura KR, McIver SC, Ranheim EA, Bresnick EH. Integrating Enhancer Mechanisms to Establish a Hierarchical Blood Development Program. Blood. 130: 7. PMID 31940664 DOI: 10.1182/Blood.V130.Suppl_1.7.7  0.539
2017 Mehta C, Johnson KD, Gao X, Ong IM, Katsumura KR, McIver SC, Ranheim EA, Bresnick EH. Integrating Enhancer Mechanisms to Establish a Hierarchical Blood Development Program. Cell Reports. 20: 2966-2979. PMID 28930689 DOI: 10.1016/J.Celrep.2017.08.090  0.656
2017 Bresnick E, Hewitt K, Mehta C, Johnson K, Matson D, Katsumura K, Gao X, McIver S, Devadas P, Hebert A, Coon J, Kim J, Ong I, Ranheim E, Dewey C, et al. Enhancer mechanisms governing developmental and regenerative hematopoietic programs Experimental Hematology. 53: S28. DOI: 10.1016/J.Exphem.2017.06.018  0.549
Show low-probability matches.